0001724999-17-000001.txt : 20171212 0001724999-17-000001.hdr.sgml : 20171212 20171211174333 ACCESSION NUMBER: 0001724999-17-000001 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20171212 DATE AS OF CHANGE: 20171211 EFFECTIVENESS DATE: 20171212 FILER: COMPANY DATA: COMPANY CONFORMED NAME: JSK Therapeutics, Inc. CENTRAL INDEX KEY: 0001724999 IRS NUMBER: 000000000 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-300466 FILM NUMBER: 171250457 BUSINESS ADDRESS: STREET 1: 9758 CERVANTES CIRCLE CITY: SANDY STATE: UT ZIP: 84092 BUSINESS PHONE: 801-971-6678 MAIL ADDRESS: STREET 1: 9758 CERVANTES CIRCLE CITY: SANDY STATE: UT ZIP: 84092 D 1 primary_doc.xml X0708 D LIVE 0001724999 JSK Therapeutics, Inc. 9758 CERVANTES CIRCLE SANDY UT UTAH 84092 801-971-6678 DELAWARE None None Corporation true Dr. Joseph Nowoslawski 9758 Cervantes Circle Sandy UT UTAH 84092 Executive Officer Director Jason Ockey 9758 Cervantes Circle Sandy UT UTAH 84092 Director Dinesh Patel 9758 Cervantes Circle Sandy UT UTAH 84092 Director Paul Shami 9758 Cervantes Circle Sandy UT UTAH 84092 Executive Officer Director Randall Peterson 9758 Cervantes Circle Sandy UT UTAH 84092 Director Other Technology Decline to Disclose 06b false 2017-11-27 false true false 0 1012835 962839 49996 false 10 0 0 0 false JSK Therapeutics, Inc. Dr. Joseph Nowoslawski Dr. Joseph Nowoslawski Chief Executive Officer 2017-12-11